Chemoinformaics analysis of 5-Hydroxymethyldihydrofuran-2-one
| Molecular Weight | 116.116 | nRot | 1 |
| Heavy Atom Molecular Weight | 108.052 | nRig | 6 |
| Exact Molecular Weight | 116.047 | nRing | 1 |
| Solubility: LogS | 0.67 | nHRing | 1 |
| Solubility: LogP | -0.522 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 16.0903 |
| nHD | 1 | BPOL | 10.6297 |
| QED | 0.478 |
| Synth | 3.117 |
| Natural Product Likeliness | 2.644 |
| NR-PPAR-gamma | 0.13 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.004 |
| HIA | 0.006 |
| CACO-2 | -4.573 |
| MDCK | 0.00151019 |
| BBB | 0.821 |
| PPB | 0.143277 |
| VDSS | 0.688 |
| FU | 0.791219 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.088 |
| CYP2c19-inh | 0.018 |
| CYP2c19-sub | 0.176 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.299 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.321 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.187 |
| CL | 6.205 |
| T12 | 0.927 |
| hERG | 0.009 |
| Ames | 0.082 |
| ROA | 0.012 |
| SkinSen | 0.316 |
| Carcinogencity | 0.428 |
| EI | 0.281 |
| Respiratory | 0.033 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.967727 |